240 related articles for article (PubMed ID: 33003084)
1. Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation.
Lindner S; Peled JU
Curr Opin Hematol; 2020 Nov; 27(6):360-367. PubMed ID: 33003084
[TBL] [Abstract][Full Text] [Related]
2. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.
Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D
Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
Shono Y; van den Brink MRM
Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
[TBL] [Abstract][Full Text] [Related]
4. Lactose drives
Stein-Thoeringer CK; Nichols KB; Lazrak A; Docampo MD; Slingerland AE; Slingerland JB; Clurman AG; Armijo G; Gomes ALC; Shono Y; Staffas A; Burgos da Silva M; Devlin SM; Markey KA; Bajic D; Pinedo R; Tsakmaklis A; Littmann ER; Pastore A; Taur Y; Monette S; Arcila ME; Pickard AJ; Maloy M; Wright RJ; Amoretti LA; Fontana E; Pham D; Jamal MA; Weber D; Sung AD; Hashimoto D; Scheid C; Xavier JB; Messina JA; Romero K; Lew M; Bush A; Bohannon L; Hayasaka K; Hasegawa Y; Vehreschild MJGT; Cross JR; Ponce DM; Perales MA; Giralt SA; Jenq RR; Teshima T; Holler E; Chao NJ; Pamer EG; Peled JU; van den Brink MRM
Science; 2019 Nov; 366(6469):1143-1149. PubMed ID: 31780560
[TBL] [Abstract][Full Text] [Related]
5. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
Staffas A; Burgos da Silva M; van den Brink MR
Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
[TBL] [Abstract][Full Text] [Related]
6. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms.
Nguyen CL; Docampo MD; van den Brink MR; Markey KA
Curr Opin Genet Dev; 2021 Feb; 66():25-35. PubMed ID: 33388483
[TBL] [Abstract][Full Text] [Related]
7. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
Shono Y; Docampo MD; Peled JU; Perobelli SM; Velardi E; Tsai JJ; Slingerland AE; Smith OM; Young LF; Gupta J; Lieberman SR; Jay HV; Ahr KF; Porosnicu Rodriguez KA; Xu K; Calarfiore M; Poeck H; Caballero S; Devlin SM; Rapaport F; Dudakov JA; Hanash AM; Gyurkocza B; Murphy GF; Gomes C; Liu C; Moss EL; Falconer SB; Bhatt AS; Taur Y; Pamer EG; van den Brink MRM; Jenq RR
Sci Transl Med; 2016 May; 8(339):339ra71. PubMed ID: 27194729
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
van Lier YF; Vos J; Blom B; Hazenberg MD
Gut Microbes; 2023; 15(1):2178805. PubMed ID: 36794370
[TBL] [Abstract][Full Text] [Related]
9. Intestinal microbiota-related effects on graft-versus-host disease.
Shono Y; Docampo MD; Peled JU; Perobelli SM; Jenq RR
Int J Hematol; 2015 May; 101(5):428-37. PubMed ID: 25812838
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.
Köhler N; Zeiser R
Front Immunol; 2018; 9():3179. PubMed ID: 30705680
[TBL] [Abstract][Full Text] [Related]
11. The composition of the intestinal microbiota after allogeneic haematopoietic stem cell transplantation and its association with graft versus host disease as assessed by 16Sribosomal ribonucleic acid.
Li DS; Wu YR; Du WH; Zhu YL; Zhang WJ; Fu Y; Yang GB
J Physiol Pharmacol; 2023 Feb; 74(1):. PubMed ID: 37245237
[TBL] [Abstract][Full Text] [Related]
12. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.
Peled JU; Devlin SM; Staffas A; Lumish M; Khanin R; Littmann ER; Ling L; Kosuri S; Maloy M; Slingerland JB; Ahr KF; Porosnicu Rodriguez KA; Shono Y; Slingerland AE; Docampo MD; Sung AD; Weber D; Alousi AM; Gyurkocza B; Ponce DM; Barker JN; Perales MA; Giralt SA; Taur Y; Pamer EG; Jenq RR; van den Brink MRM
J Clin Oncol; 2017 May; 35(15):1650-1659. PubMed ID: 28296584
[TBL] [Abstract][Full Text] [Related]
14. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
Parco S; Benericetti G; Vascotto F; Palmisciano G
Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
[TBL] [Abstract][Full Text] [Related]
15. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
Kumari R; Palaniyandi S; Hildebrandt GC
Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) - Case series.
Gray AN; Tobin NH; Moore TB; Li F; Aldrovandi GM
Int J Med Microbiol; 2023 May; 313(3):151580. PubMed ID: 37121094
[TBL] [Abstract][Full Text] [Related]
17. TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.
Kumari R; Palaniyandi S; Strattan E; Huang T; Kohler K; Jabbour N; Dalland J; Du J; Kesler MV; Chen YH; Hildebrandt GC
Transplantation; 2020 Mar; 104(3):500-510. PubMed ID: 31634333
[TBL] [Abstract][Full Text] [Related]
18. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.
DeFilipp Z; Peled JU; Li S; Mahabamunuge J; Dagher Z; Slingerland AE; Del Rio C; Valles B; Kempner ME; Smith M; Brown J; Dey BR; El-Jawahri A; McAfee SL; Spitzer TR; Ballen KK; Sung AD; Dalton TE; Messina JA; Dettmer K; Liebisch G; Oefner P; Taur Y; Pamer EG; Holler E; Mansour MK; van den Brink MRM; Hohmann E; Jenq RR; Chen YB
Blood Adv; 2018 Apr; 2(7):745-753. PubMed ID: 29592876
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.
Fujiwara H
Front Immunol; 2021; 12():703298. PubMed ID: 34512627
[TBL] [Abstract][Full Text] [Related]
20. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
